Natural products to drugs: natural product-derived compounds in clinical trials. - Wikidata - wikimedia - TriplyDB

Natural products to drugs: natural product-derived compounds in clinical trials.

Natural products to drugs: natural product-derived compounds in clinical trials.

http://www.wikidata.org/entity/Q34780898

about

Sloth hair as a novel source of fungi with potent anti-parasitic, anti-cancer and anti-bacterial bioactivity Discovery and resupply of pharmacologically active plant-derived natural products: A review Discovery of natural product anticancer agents from biodiverse organisms Natural product disaccharide engineering through tandem glycosyltransferase catalysis reversibility and neoglycosylation Sceptrin, a marine natural compound, inhibits cell motility in a variety of cancer cell lines.Tubulin-interactive natural products as anticancer agents The Traditional Medicine and Modern Medicine from Natural Products Refined Spruce Resin to Treat Chronic Wounds: Rebirth of an Old Folkloristic Therapy Streptomyces Bacteria as Potential Probiotics in Aquaculture Discovery of new anticancer agents from higher plants Titration-Based Screening for Evaluation of Natural Product Extracts: Identification of an Aspulvinone Family of Luciferase Inhibitors A conserved motif flags acyl carrier proteins for β-branching in polyketide synthesis Synthesis of Bisindole Alkaloids from the Apocynaceae Which Contain a Macroline or Sarpagine Unit: A Review Plant Alkaloids as Antiplatelet Agent: Drugs of the Future in the Light of Recent Developments Enzymatic methods for glyco(diversification/randomization) of drugs and small molecules Sustained proliferation in cancer: Mechanisms and novel therapeutic targets Pretubulysin: from hypothetical biosynthetic intermediate to potential lead in tumor therapy Potential Compounds for Oral Cancer Treatment: Resveratrol, Nimbolide, Lovastatin, Bortezomib, Vorinostat, Berberine, Pterostilbene, Deguelin, Andrographolide, and Colchicine Photochemical Approaches to Complex Chemotypes: Applications in Natural Product Synthesis Modern natural products drug discovery and its relevance to biodiversity conservation New Approach for the Development of Improved Traditional Medicine: Case of a Preparation of an Oral Hypoglycemic Medicine from Laportea ovalifolia (Schumach. & Thonn.) Chew. (Urticaceae).Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targets.Patenting bioactive molecules from biodiversity: the Brazilian experience.Fractionated marine invertebrate extract libraries for drug discovery.Enhancing the divergent activities of betulinic acid via neoglycosylation.Extracts from Cladiella australis, Clavularia viridis and Klyxum simplex (soft corals) are capable of inhibiting the growth of human oral squamous cell carcinoma cells Total synthesis of a library of designed hybrids of the microtubule-stabilising anticancer agents taxol, discodermolide and dictyostatin.Natural Products as a Foundation for Drug Discovery.Probing chemical space with alkaloid-inspired libraries.The continuing search for antitumor agents from higher plants Role of natural product diversity in chemical biology.Catalyst recognition of cis-1,2-diols enables site-selective functionalization of complex molecules Potential of plant-derived natural products in the treatment of leukemia and lymphoma Recent application of analytical methods to phase I and phase II drugs development: a review.Obionin B: An o-pyranonaphthoquinone decaketide from an unidentified fungus (MSX 63619) from the Order Pleosporales Development of a general, sequential, ring-closing metathesis/intramolecular cross-coupling reaction for the synthesis of polyunsaturated macrolactones Antibiotic discovery in the twenty-first century: current trends and future perspectives.Nitroso Diels-Alder (NDA) reaction as an efficient tool for the functionalization of diene-containing natural products Chemistry and biology of rocaglamides (= flavaglines) and related derivatives from aglaia species (meliaceae)Ethnopharmacology and integrative medicine - Let the history tell the future.

P2860

Q21132370-545FA65C-00DF-488D-9985-024CAB803CC1 Q22252341-D5EB9D5A-2983-4110-90BA-5ECBC73FCAFF Q24605488-6A1CC3C8-A198-40A2-A4CB-000647883C80 Q24618494-4145D392-A8D1-436F-9218-8A12A462FD0A Q24645263-19A86D5B-F014-44E1-A6D7-6CDCFA8DF2B5 Q24650163-E65F7165-7EF2-4DBE-80E3-928CC4D9B6AE Q26748266-B1B52F38-7F24-4250-A53A-7495A100430B Q26748522-231B3AFF-EDEB-4530-9F90-A924029BA2EF Q26768115-4DA1C343-FFC0-4E20-B31C-3644DA1DDF5E Q27006814-3C729FFD-4AD9-400D-9178-60D0CBB25F4B Q27675809-2CBE339A-3925-408B-BEE8-466BA21BDECC Q27680011-A255707C-E335-4561-8DD1-9E03E60315C1 Q28073089-E7561FCD-6F25-4FF8-A616-36C6E6F86FAF Q28076248-C2F25C4B-F6D7-48E8-944B-E2256F3D6E70 Q28247479-FE2BF20D-5E0A-4EFE-A529-E6121D1F6E05 Q28396388-3088867E-8D52-476C-BB62-BBB916154D06 Q28483792-E424A1D9-E8B0-4EA5-A761-D11AA5F0FFCD Q28550690-39D201CA-32BF-441E-B764-CFA0A2EBCBA8 Q28830059-A3EFFBCC-AAD6-429D-B2F5-AD689B8B2D86 Q29353836-F038DBCB-2EE7-4F88-B5D0-9283DAC33A51 Q30387078-80434BAD-51E1-4B97-88C4-92F8ADE6CC7F Q30505764-DF35D47E-D164-4CE4-A312-18F14CCC4BF7 Q30977203-47FF1F35-2A70-4CEE-BB64-5764548992FD Q33348500-1F163133-B10F-4AFC-B819-D386D87474D4 Q33395056-2376D800-8C5B-4F27-8B98-BEEABEB23BAD Q33403201-79F470D9-AD88-431E-B273-AEE7ACDEBE27 Q33519974-E401CE08-4509-4B8F-A800-64D5BB9EFA6E Q33617301-2DA8DF1D-BEB0-48A1-A7AD-60D80B55C85A Q33626989-5E4F3039-1DED-4C6A-9107-26D7D5144F7C Q33717343-42DA31EB-780C-49EB-807C-D51507990325 Q33871943-D05AFE5E-2923-4EA6-9A9E-5917ADDF8A5F Q33942260-31688DE7-2241-4B55-8EA6-726FFEA16585 Q33942845-695E5CFE-9815-47F7-A71C-ED8D9DE1C0CE Q33997398-58F6E99E-6E2D-4A31-9FC2-07F179D9E929 Q34057178-C7AB0B42-32D3-4D2D-A4BE-622F5826E4A1 Q34073280-328D9DE9-27EB-4232-887F-8BEA680C45B5 Q34121033-5B7328BC-95FA-47A8-82D7-72F545F36AD5 Q34167537-870D40F0-16C5-432B-963C-9655F372907B Q34207395-DA9D6B60-A94F-434C-A77F-B6BEF3D4B5CB Q34207637-3884592B-8623-43E4-B038-A91D49E828E6

P2860

Natural products to drugs: natural product-derived compounds in clinical trials.

http://www.wikidata.org/entity/Q34780898

description

2008 nî lūn-bûn

@nan

2008 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Natural products to drugs: natural product-derived compounds in clinical trials.

@ast

Natural products to drugs: natural product-derived compounds in clinical trials.

@en

Natural products to drugs: natural product-derived compounds in clinical trials.

@nl

type

label

Natural products to drugs: natural product-derived compounds in clinical trials.

@ast

Natural products to drugs: natural product-derived compounds in clinical trials.

@en

Natural products to drugs: natural product-derived compounds in clinical trials.

@nl

prefLabel

Natural products to drugs: natural product-derived compounds in clinical trials.

@ast

Natural products to drugs: natural product-derived compounds in clinical trials.

@en

Natural products to drugs: natural product-derived compounds in clinical trials.

@nl

P1433

Q34780898-0EA705FB-29A1-479C-A693-E528CA61938B

P1476

Q34780898-62BF95DB-91E9-4F9D-A927-8890A95A349D

P2860

Q34780898-00F258ED-BC52-4798-B2A6-E67CE1FE60B3

Q34780898-03D93CD4-4D45-4E53-9EDC-2C415E25EAA1

Q34780898-0444463D-B2DB-4E4D-A5F3-9E44389A7C87

Q34780898-295A7291-595E-4407-8D74-7A9846EBC03D

Q34780898-2FC01E57-02B8-40B0-B7E4-904B1BE55105

Q34780898-376844A4-6C88-40F1-B19C-4540D4309DD3

Q34780898-43C2FF9B-6DA1-4226-BD83-17E7234FFAB4

Q34780898-44F67E43-29F7-4988-8983-F24ADA816E07

Q34780898-512E1A90-5478-4433-A2A7-8C67FDABC8D6

Q34780898-59ABF909-AC04-4E92-8266-943BAC22B7F7

P304

Q34780898-26660F8E-020A-4B37-ACAA-8D0A043D7683

P31

Q34780898-A54AE1FB-9852-43FA-BAD3-3B7C44A44716

P356

Q34780898-755E25C2-C73F-46C7-AA52-506312646C98

P433

Q34780898-A9374121-B15F-4726-95EF-FEE7894D3CEC

P478

Q34780898-573E9A68-405C-4913-B008-D84F71F65A6A

P50

Q34780898-2773B8F7-BB8D-4AE6-9672-EA2C1F34053E

P577

Q34780898-D4ADAB29-F826-4A13-A75E-739438374735

P5875

Q34780898-5CC18B45-E5E5-4C82-9E43-FBFEC04A955E

P698

Q34780898-DAF19252-81E8-439E-8BCC-71A8B1433F66

P356

P1433

Natural Product Reports

P1476

Natural products to drugs: natural product-derived compounds in clinical trials.

@en

P2860

Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle

Faropenem medoxomil

Thienamycin, a new beta-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties

Iminosugars as possible broad spectrum anti hepatitis virus agents: the glucovirs and alkovirs.

Recent advances in the new generation taxane anticancer agents.

The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept.

Incretins and their role in the management of diabetes.

In vitro antibacterial activity and beta-lactamase stability of CP-70,429 a new penem antibiotic.

Neutrophils are a key component of the antitumor efficacy of topical chemotherapy with ingenol-3-angelate.

Action of celgosivir (6 O-butanoyl castanospermine) against the pestivirus BVDV: implications for the treatment of hepatitis C.

P304

475-516

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/B514294F

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5352029

http://www.w3.org/2001/XMLSchema#string

P698

18497896

http://www.w3.org/2001/XMLSchema#string